Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.


NDAQ:PMN - Post by User

Comment by bball67on Sep 20, 2022 12:43pm
161 Views
Post# 34974113

RE:The Boston Fix is in

RE:The Boston Fix is in

Most farmers are accurate and precise because they have to be.Farmer Betty, you have never let accuracy and preciseness stand in your way. This is how it works in corporate America in these kind of circumstances: Step one-no longer CEO, step 2-no longer Chairman but still on board, step 3-no longer on the board which will be three years, maybe less. This is done to avoid a lawsuit and limit your liability when you have no cause for firing someone. The consulting agreement of $225k is like severance. It is $225k a year whether he works zero or 40 hours a month. You start multiplying 160 hours by some rate and come up with $900k, what the hell are you doing? It is only $225k a year, period. You did not pass contract law.

Secondly, you say the "Boston Fix is in". I know you won't respond but what the heck does that mean?

<< Previous
Bullboard Posts
Next >>